A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
NEWSAerie Pharmaceuticals Announces Positive Topline Results of Netarsudil... Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory... Aerie Pharmaceuticals Reports Topline Result from Rhopressa®...
Jan 16, 4:00 PM ET
52 - WEEK LOW/HIGH